Cite
Phase I Pharmacokinetic Study of S-1 Granule and Nedaplatin for Patients with Recurrent/Metastatic Head and Neck Cancer
MLA
Kaoru Tanaka, et al. “Phase I Pharmacokinetic Study of S-1 Granule and Nedaplatin for Patients with Recurrent/Metastatic Head and Neck Cancer.” Annals of Oncology, vol. 24, Nov. 2013, p. ix40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8ea8e02f72360c0167286f0fe63e95ee&authtype=sso&custid=ns315887.
APA
Kaoru Tanaka, Hisato Kawakami, Masayuki Takeda, Hidetoshi Hayashi, Kazuhiko Nakagawa, Isamu Okamoto, Shinichi Nishina, Katsumi Doi, Kunio Okamoto, & Shinya Ueda. (2013). Phase I Pharmacokinetic Study of S-1 Granule and Nedaplatin for Patients with Recurrent/Metastatic Head and Neck Cancer. Annals of Oncology, 24, ix40.
Chicago
Kaoru Tanaka, Hisato Kawakami, Masayuki Takeda, Hidetoshi Hayashi, Kazuhiko Nakagawa, Isamu Okamoto, Shinichi Nishina, Katsumi Doi, Kunio Okamoto, and Shinya Ueda. 2013. “Phase I Pharmacokinetic Study of S-1 Granule and Nedaplatin for Patients with Recurrent/Metastatic Head and Neck Cancer.” Annals of Oncology 24 (November): ix40. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8ea8e02f72360c0167286f0fe63e95ee&authtype=sso&custid=ns315887.